 | • レポートコード：MRC2108A445 • 出版社/出版日：Mordor Intelligence / 2021年7月31日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、薬物乱用治療の世界市場規模が2021年から2026年の間に7.2％成長すると予測しています。本調査資料では、世界の薬物乱用治療市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、治療別（アルコール依存症治療、タバコ・ニコチン中毒治療、薬物中毒治療、その他）分析、治療別（同種幹細胞治療、自家幹細胞治療、同系幹細胞治療）分析、地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）、競争状況、市場機会/将来の見通しなどを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・薬物乱用治療の世界市場規模：治療別（アルコール依存症治療、タバコ・ニコチン中毒治療、薬物中毒治療、その他） ・薬物乱用治療の世界市場規模：流通チャンネル別（病院薬局、小売薬局、その他） ・薬物乱用治療の世界市場規模：治療別（同種幹細胞治療、自家幹細胞治療、同系幹細胞治療） ・薬物乱用治療の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Alkermes PLC、Abbvie Inc.、Cipla Ltd.、GlaxoSmithKline PLC、Mallinckrodt LLC、Indivior PLC、Pfizer Inc. 、Sanofi SA、Teva Pharmaceutical Industries Ltd） ・市場機会/将来の見通し |
The Substance Abuse Treatment Market is expected to register a CAGR of nearly 7.2% during the forecast period (2021-2026).
Due to Covid-19 pandemic, the rehabilitation centers are have taken necessary steps in coordination with the guidelines set up by the the Center for Disease Control (CDC) and the Food and Drug Administration (FDA), as well as World Health Organization; the prognosis of patients co-occurring conditions such as chronic obstructive pulmonary disease, cardiovascular disease, and other respiratory diseases is worsened with COVID impacting the lives of substance abuse and alcohol addicted patients.
Moreover, the substance abuse has affected large population of United States each year. There has been increased addition related to alcohol dependence/abuse, marijuana, tobacco, cocaine, and other abusive products present in the market.Alcohol abuse in the United States is among the top five leading preventable cause of death, with about a million are being treated every year. With the lockdown under effect, there is large cases of postponing or cancelling rehab for substance abuse treatment centers until the crisis subsides. In addition, the federal government has eased the restriction on prescribing controlled substances by telehealth. The U.S. Drug Enforcement Administration (DEA), has also issued guidelines allowing practitioners to prescribe certain controlled substances remotely to patients in a treatment program for self-administration.
Other factors that are driving the market growth includes rising drug awareness campaigns and prevention programs, and high number of addicted population.
The rise in the drug awareness campaigns and associated prevention programs is one of the primary factors linked to the growth of the market studied. It includes rising patient awareness, higher treatment-seeking rate with increased government intervention, and encouragement to curb substance abuse in several countries. In November 2019, Himachal Pradesh (India) CM launched a campaign on drug abuse prevention to collectively fight the evil of drug abuse by making the campaign a mass movement for creation of ill effects of drug abuse in the state.
Additionally, an increasing number of treatment centers that have collaborations with private recovery facilities are entering the market, thus helping in the expansion of treatment access to a higher number of people in society.
However, the discontinuation of behavioral therapies often leads to a relapse of addiction, which is a crucial factor hindering the growth of the market. Many patients opt for outpatient care for the treatment of drug dependence. In addition, the high reluctance of individuals for accessing treatment modalities and poor treatment compliance in some countries hinder the growth of the market studied.
Key Market Trends
Tobacco/Nicotine Addiction Treatment is Expected to Dominate the Market
Tobacco and its usage through consumption and smoking are harmful, as it kills half of its users globally, as stated by the World Health Organization. The data from the World Health Organization (WHO) also states that tobacco kills more than 8 million people each year. More than 7 million of those deaths are the result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to second-hand smoke. Moreover, the usage of tobacco is more in developing and underdeveloped countries. Hence as these economies as not as strong as developed economies, the burden of treating such population is more on these economies.
The utilization of electric cigarette is also contributing to the high usage of tobacco across the developing and developed nations. Despite the understanding of the general population that E-Cigarette is less harmful, studies have indicated that the E-cigarette consumption leads to several serious health issues associated with tobacco. However, the urban countries are witnessing large number of E-cigarette users.
Additionally, awareness campaigns and programs initiated by the government are propelling the market studied. In July 2019, National Jewish Health launched vaping and tobacco cessation program to help with youth vaping epidemic in the United states. Hence, all these factors are expected to help this market grow.
North America is expected to Dominate the Market During the Forecast Period
North America is expected to dominate the market, due to increasing awareness compaign, and a huge population base in the area. In December 2019, Florida Government has launched a nationwide New Drug Education Campaign to prevent drug or substance abuse by the youth of Florida.
According to the Center for Disease Control and Prevention, tobacco product use among US youth is increasing. As per this data, in 2018, more than 1 in 4 high school students and about 1 in 14 middle school students had used a tobacco product. This was observed to have considerably increased from 2017, which was driven by an increase in e-cigarette use. In the US, e-cigarette use increased from approximately 12% to more than 20% among high school students and from 3.3% to 4.9% among middle school students from 2017 to 2018.
Various initiatives are being implemented by the US government to monitor the symptoms and to determine whether a population is abusing drugs and other substances. For instance, Patients and Communities Act of 2018 is the latest law implemented by the country for counter-acting drug abuse.
The United States has a developed healthcare system that has one of the largest expenditures on healthcare. Its investment in research and development is also large. As a result of these factors, a large population is able to get the required treatment it needs. Owing to these factors, the substance abuse treatment regional market is expected to be one of the largest and is also expected to grow in the future.
Competitive Landscape
The majority of the substance abuse treatment products are being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the market grow.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Drug Awareness Campaigns and Prevention Programs
4.2.2 High Number of Addicted Population
4.3 Market Restraints
4.3.1 Reluctance of Individuals for Accessing Treatment and Discontinuation of the Behavioral Therapies
4.3.2 Poor Treatment Compliance in Some Countries
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Treatment Type
5.1.1 Alcohol Addiction Treatment
5.1.2 Tobacco/Nicotine Addiction Treatment
5.1.3 Drug Abuse Treatment
5.1.4 Other Treatment Types
5.2 By Distribution Channel
5.2.1 Hospital Pharmacies
5.2.2 Retail Pharmacies
5.2.3 Other Distribution Channels
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Alkermes PLC
6.1.2 Abbvie Inc.
6.1.3 Cipla Ltd.
6.1.4 GlaxoSmithKline PLC
6.1.5 Mallinckrodt LLC
6.1.6 Indivior PLC
6.1.7 Pfizer Inc.
6.1.8 Sanofi SA
6.1.9 Teva Pharmaceutical Industries Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS